Severance Hospital

Public research footprint of Severance Hospital, compiled from the ClinicalTrials.gov public registry.

2,930

Registered studies

926

Active

523

Recruiting now

1,395

Completed

235

Stopped or withdrawn

Most-studied conditions

Endometrial Dedifferentiated Carcinoma · Endometrial Clear Cell Adenocarcinoma · Non-Muscle Invasive Bladder Neoplasms · Endometrial Mixed Cell Adenocarcinoma

Recently updated registry entries

NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)
NCT03767244 — A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced… (Active Not Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Severance Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.